EVENTS & CONFERENCES

Let’s connect in person

We present new platform data at antibody engineering, ADC, and other conferences throughout the year. Upcoming shows are listed below, along with all posters, decks, and talks from the ones already behind us.

Upcoming events

PEGS Europe 2026

Podium presentation

PEGS Europe
November 17-19, 2026 Lisbon, Portugal Lisbon Congress Center Booth 200

At this show

Learn how Invenra’s mAb Discovery Services can deliver therapeutic-quality antibody leads in just eight weeks, including new service packages and transparent pricing. You’ll also see how the B-Body® Bispecific Platform enables the development of high-quality bispecific antibodies ready to advance your pipeline, and how the T-Body™ Trispecific Platform expands targeting capabilities by engaging three distinct antigens.

C3C: Advancing Multispecific Antibodies and Combination Therapy to the Clinic

Details coming soon

Belinda Wenke
Wednesday, November 18 @ 5:30pm

BIO–Europe 2026

Scheduling partnering meetings now!

BEU-logo-color
November 9-11, 2026 Cologne, Germany Koelnmesse

At this show

We’re currently scheduling partnering meetings for BIO-Europe 2026. We'd love to connect in person if you're attending.

Find us through the event's partneringONE portal.

Past events

2026

World ADC Summit 2026

Debut of 52 Views of Cancer + ADC data

adc-event
October 12-15, 2026 San Diego, CA, USA Town and Country Resort Booth 35

At this show

At the 17th World ADC Conference in San Diego, Invenra presented new preclinical data on two T-Body™ trispecific ADC programs and launched 52 Views of Cancer, a playing card deck with original artwork by a cancer patient, survivor, or family member.

52 Views of Cancer

A one-of-a-kind deck of playing cards illustrated by people who know cancer firsthand.

From Bispecific to Trispecific Antibodies: Reimagining the Next Generation of ADCs
Bonnie Hammer, PhD

World Bispecific Summit

Podium, poster, and evening event

World-Bispecific-US-Summit-logo
September 14-17, 2026 Boston, MA, USA
From Bi- to Trispecific Antibodies: Reimagining the Next Generation of ADCs (Presentation Updated)
Andrew Garfoot
Invenra’s B-Body and T-Body Platforms: Rapid, Comprehensive Screening for Optimal Multispecific ADC Development
Science Social with Twist Bioscience

A special event, Wednesday, 16 September, 7:00–10:00 pm at Moxies, 899 Congress St, Boston.

8th Annual T-Cell Engager Therapeutics Summit

Presentation · T-cell engagers

HW260209-69173-8th-T-Cell-Engager-Therapeutics-Summit-logo-2-scaled
June 23-25, 2026 San Diego, CA, USA
TAA/CD3/CD28 Co-Stimulatory Antibody Optimization Drives Superior Tumor-Directed T-Cell Engagement
Joe Goldufsky, PhD

22nd Annual PEGS Boston

Presentation · T-cell engagers and ADCs

peg_stacked_logo
May 11-15, 2026 Boston, MA, USA
Engineering Trispecific CD3×CD28 T-Cell Engagers: Systematic Optimization of Affinity, Format, and Co-Stimulation
Brian Glaser, PhD
From Bi- to Trispecific Antibodies: Reimagining the Next Generation of ADCs (Presentation Updated)
Bonnie Hammer, PhD
2025

Antibody Engineering & Therapeutics

Presentation · Trispecific platform

AETUSA-Colour-5781ac2d8ae21a6fb46fd761b0ce6e73
December 16, 2025 San Diego, CA, USA
T-Body: A Novel Trispecific Antibody Platform to Accelerate and De-Risk Drug Discovery
Nick Marshall, PhD

16th Annual World ADC

Presentation · ADC screening

16thWorldADC-logo
November 4, 2025 San Diego, CA, USA
12×12 Matrix Screening with B-Body® and T-Body Platforms: Comprehensive, Rapid Discovery of Multispecific Antibodies for ADCs Targeting Breast Cancer
Bonnie Hammer, PhD